Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Oct-13 9:06 PM View:  | Coles N Anthony Chairman & CEO Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 105,566 | $125.00 | $13,195,800.00 | (80%) 131.2K to 25.63K | |
| 03-Oct-13 9:10 PM View: | Foster-Cheek Kaye I SVP, Global Human Resources | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 21,400 | $125.00 | $2,675,000.00 | (79%) 27.07K to 5.67K | |
| 03-Oct-13 9:06 PM View: | Coles N Anthony Chairman & CEO Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 25,632 | $125.00 | $3,204,000.00 | (100%) 25.63K to 0 | |
| 03-Oct-13 9:18 PM View: | Fust Matthew K EVP & Chief Financial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 31,150 | $125.00 | $3,893,750.00 | (77%) 40.3K to 9.15K | |
| 03-Oct-13 9:03 PM View: | Ringo William R Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 7,737 | $125.00 | $967,125.00 | (100%) 7.74K to 0 | |
| 03-Oct-13 8:57 PM View: | Torley Helen EVP, Chief Commercial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 28,575 | $125.00 | $3,571,880.00 | (80%) 35.91K to 7.34K | |
| 03-Oct-13 8:52 PM View: | Wiggans Thomas G Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 2,100 | $125.00 | $262,500.00 | (26%) 8.12K to 6.01K | |
| 03-Oct-13 9:01 PM View: | Lundberg Magnus Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 2,100 | $125.00 | $262,500.00 | (15%) 14.22K to 12.12K | |
| 03-Oct-13 9:39 PM View: | Cagnoni Pablo J EVP, Global R&D and Tech Ops | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 16,257 | $125.00 | $2,032,120.00 | (100%) 16.26K to 0 | |
| 03-Oct-13 9:24 PM View: | Wood Julianna R VP, Public Affairs | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 9,824 | $125.00 | $1,228,000.00 | (98%) 10.02K to 0.2K | |
| 03-Oct-13 8:52 PM View: | Lasowski Juergen EVP, Corp. Dev & Strategy | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 30,250 | $125.00 | $3,781,250.00 | (94%) 32.08K to 1.83K | |
| 03-Oct-13 8:57 PM View: | Torley Helen EVP, Chief Commercial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 7,336 | $125.00 | $917,000.00 | (100%) 7.34K to 0 | |
| 03-Oct-13 9:28 PM View: | Shema Suzanne M EVP,GC and Corp. Secretary | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 28,150 | $125.00 | $3,518,750.00 | (81%) 34.62K to 6.47K | |
| 03-Oct-13 8:52 PM View: | Lasowski Juergen EVP, Corp. Dev & Strategy | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 1,833 | $125.00 | $229,125.00 | (100%) 1.83K to 0 | |
| 03-Oct-13 8:53 PM View: | Lyle Corinne H Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 2,100 | $125.00 | $262,500.00 | (100%) 2.1K to 0 | |
| 03-Oct-13 9:18 PM View: | Fust Matthew K EVP & Chief Financial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 9,153 | $125.00 | $1,144,120.00 | (100%) 9.15K to 0 | |
| 03-Oct-13 9:10 PM View: | Foster-Cheek Kaye I SVP, Global Human Resources | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 5,666 | $125.00 | $708,250.00 | (100%) 5.67K to 0 | |
| 03-Oct-13 9:30 PM View: | Wierenga Wendall D Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 9,080 | $125.00 | $1,135,000.00 | (100%) 9.08K to 0 | |
| 03-Oct-13 9:24 PM View: | Wood Julianna R VP, Public Affairs | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 200 | $125.00 | $25,000.00 | (100%) 0.2K to 0 | |
| 03-Oct-13 9:01 PM View: | Lundberg Magnus Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 12,116 | $125.00 | $1,514,500.00 | (100%) 12.12K to 0 | |
| 03-Oct-13 9:28 PM View: | Shema Suzanne M EVP,GC and Corp. Secretary | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 6,468 | $125.00 | $808,500.00 | (100%) 6.47K to 0 | |
| 03-Oct-13 9:30 PM View: | Wierenga Wendall D Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 2,100 | $125.00 | $262,500.00 | (19%) 11.18K to 9.08K | |
| 03-Oct-13 8:50 PM View: | Goddard Paul Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 12,790 | $125.00 | $1,598,750.00 | (100%) 12.79K to 0 | |
| 03-Oct-13 9:24 PM View: | Wood Julianna R VP, Public Affairs | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 9,550 | $125.00 | $1,193,750.00 | (49%) 19.57K to 10.02K | |
| 03-Oct-13 9:03 PM View: | Grillo Lopez Antonio J Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 2,100 | $125.00 | $262,500.00 | (100%) 2.1K to 0 | |
| 03-Oct-13 8:50 PM View: | Goddard Paul Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 2,100 | $125.00 | $262,500.00 | (14%) 14.89K to 12.79K | |
| 03-Oct-13 8:52 PM View: | Wiggans Thomas G Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 6,015 | $125.00 | $751,875.00 | (100%) 6.01K to 0 | |
| 03-Oct-13 9:03 PM View: | Ringo William R Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 2,100 | $125.00 | $262,500.00 | (21%) 9.84K to 7.74K | |
| 05-Sep-13 7:44 PM View: | Torley Helen EVP, Chief Commercial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 03-Sep-13 | Payment of Exercise | 2,099 | $123.62 | $259,478.00 | (6%) 38.01K to 35.91K | (< 1%) |
| 14-Aug-13 6:23 PM View: | Torley Helen EVP, Chief Commercial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 12-Aug-13 | Option Exercise | 8,250 | $34.30 | $283,000.00 | 17% 47.65K to 55.9K | |
| 14-Aug-13 6:23 PM View: | Torley Helen EVP, Chief Commercial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 12-Aug-13 | Market Sale (Planned) | 1,061 | $126.89 | $134,631.00 | (2%) 47.65K to 46.59K | 3% |
| 14-Aug-13 6:23 PM View: | Torley Helen EVP, Chief Commercial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 12-Aug-13 | Market Option Sale (Planned) | 8,250 | $126.89 | $1,046,850.00 | (15%) 55.9K to 47.65K | 3% |
| 12-Aug-13 7:11 PM View: | Fust Matthew K EVP & Chief Financial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 08-Aug-13 | Market Sale (Planned) | 2,492 | $128.21 | $319,499.00 | (6%) 42.8K to 40.3K | 4% |
| 08-Aug-13 8:21 PM View: | Shema Suzanne M EVP, GC and Corp. Secretary | Onyx Pharmaceuticals Inc. (ONXX) | 07-Aug-13 | Market Option Sale (Planned) | 4,052 | $131.86 | $534,297.00 | (10%) 38.67K to 34.62K | 6% |
| 08-Aug-13 8:21 PM View: | Shema Suzanne M EVP, GC and Corp. Secretary | Onyx Pharmaceuticals Inc. (ONXX) | 07-Aug-13 | Option Exercise | 4,052 | $34.31 | $139,004.00 | 12% 34.62K to 38.67K | |
| 08-Aug-13 8:21 PM View: | Foster-Cheek Kaye I SVP, Global Human Resources | Onyx Pharmaceuticals Inc. (ONXX) | 06-Aug-13 | Option Exercise | 8,878 | $31.15 | $276,586.00 | 33% 27.07K to 35.94K | |
| 08-Aug-13 8:21 PM View: | Foster-Cheek Kaye I SVP, Global Human Resources | Onyx Pharmaceuticals Inc. (ONXX) | 06-Aug-13 | Market Option Sale (Planned) | 8,878 | $132.81 | $1,179,090.00 | (25%) 35.94K to 27.07K | 7% |
| 31-Jul-13 7:48 PM View: | Grillo Lopez Antonio J Director | Onyx Pharmaceuticals Inc. (ONXX) | 30-Jul-13 | Market Sale (Planned) | 1,500 | $131.26 | $196,890.00 | (42%) 3.6K to 2.1K | 6% |
| 31-Jul-13 7:48 PM View: | Lyle Corinne H Director | Onyx Pharmaceuticals Inc. (ONXX) | 30-Jul-13 | Market Sale (Planned) | 1,500 | $131.26 | $196,890.00 | (42%) 3.6K to 2.1K | 6% |
| 29-Jul-13 7:45 PM View: | Fust Matthew K EVP & Chief Financial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 26-Jul-13 | Market Sale (Planned) | 6,043 | $130.50 | $788,612.00 | (12%) 48.84K to 42.8K | 5% |
| 29-Jul-13 7:46 PM View: | Grillo Lopez Antonio J Director | Onyx Pharmaceuticals Inc. (ONXX) | 26-Jul-13 | Market Option Sale (Planned) | 2,000 | $130.50 | $261,000.00 | (36%) 5.6K to 3.6K | 5% |
| 29-Jul-13 7:46 PM View: | Grillo Lopez Antonio J Director | Onyx Pharmaceuticals Inc. (ONXX) | 26-Jul-13 | Option Exercise | 2,000 | $76.79 | $153,580.00 | 56% 3.6K to 5.6K | |
| 10-Jul-13 7:28 PM View: | Shema Suzanne M EVP, GC and Corp. Secretary | Onyx Pharmaceuticals Inc. (ONXX) | 08-Jul-13 | Market Option Sale (Planned) | 4,052 | $135.76 | $550,100.00 | (10%) 38.67K to 34.62K | 9% |
| 10-Jul-13 7:28 PM View: | Shema Suzanne M EVP, GC and Corp. Secretary | Onyx Pharmaceuticals Inc. (ONXX) | 08-Jul-13 | Option Exercise | 4,052 | $34.30 | $139,002.00 | 12% 34.62K to 38.67K | |
| 05-Jul-13 4:03 PM View: | Fust Matthew K EVP & Chief Financial Officer | Onyx Pharmaceuticals Inc. (ONXX) | 02-Jul-13 | Market Sale (Planned) | 1,551 | $132.80 | $205,973.00 | (3%) 50.39K to 48.84K | 7% |
| 02-Jul-13 6:53 PM View: | Wood Julianna R VP, Public Affairs | Onyx Pharmaceuticals Inc. (ONXX) | 01-Jul-13 | Market Option Sale (Planned) | 2,304 | $132.63 | $305,580.00 | (11%) 21.88K to 19.57K | 7% |
| 02-Jul-13 6:54 PM View: | Lasowski Juergen EVP, Corp. Dev & Strategy | Onyx Pharmaceuticals Inc. (ONXX) | 01-Jul-13 | Market Option Sale (Planned) | 25,375 | $132.63 | $3,365,490.00 | (44%) 57.46K to 32.08K | 7% |
| 02-Jul-13 6:53 PM View: | Lyle Corinne H Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Jul-13 | Market Sale (Planned) | 5,000 | $132.63 | $663,150.00 | (58%) 8.6K to 3.6K | 7% |
| 02-Jul-13 6:53 PM View: | Goddard Paul Director | Onyx Pharmaceuticals Inc. (ONXX) | 01-Jul-13 | Market Option Sale (Planned) | 6,000 | $132.21 | $793,278.00 | (29%) 20.89K to 14.89K | 7% |
| 02-Jul-13 6:53 PM View: | Wood Julianna R VP, Public Affairs | Onyx Pharmaceuticals Inc. (ONXX) | 01-Jul-13 | Option Exercise | 2,304 | $33.55 | $77,293.70 | 12% 19.57K to 21.88K |
